Search Results

You are looking at 231 - 240 of 1,245 items for :

  • Refine by Access: All x
Clear All
Full access

Prashant Gabani, Emily Merfeld, Amar J. Srivastava, Ashley A. Weiner, Laura L. Ochoa, Dan Mullen, Maria A. Thomas, Julie A. Margenthaler, Amy E. Cyr, Lindsay L. Peterson, Michael J. Naughton, Cynthia Ma, and Imran Zoberi

advanced TNBC typically receive chemotherapy, surgery, and radiation therapy (RT). More recently, the concept of neoadjuvant chemotherapy (NAC) followed by surgery and RT has been introduced in women with locally advanced or palpable TNBC, 6 because TNBC

Full access

James Sun, Brittany J. Mathias, Christine Laronga, Weihong Sun, Jun-Min Zhou, William J. Fulp, John V. Kiluk, and M. Catherine Lee

, paresthesias, and lymphedema). 1 , 2 Currently, there is sufficient evidence to support omission of completion axillary lymph node dissection (CLND) in patients undergoing breast-conserving surgery (BCS) with micrometastatic or macrometastatic disease in up to

Full access

William R. Kennedy, Christopher Tricarico, Prashant Gabani, Ashley A. Weiner, Michael B. Altman, Laura L. Ochoa, Maria A. Thomas, Julie A. Margenthaler, Souzan Sanati, Lindsay L. Peterson, Cynthia X. Ma, Foluso O. Ademuyiwa, and Imran Zoberi

occurrence of a pathologic complete response (pCR) after NAC. There has been some variation in how pCR has been defined in the literature, 7 but is generally defined as a lack of all signs of invasive carcinoma in tissue removed by surgery after treatment

Full access

George L. Jackson, Leah L. Zullig, S. Yousuf Zafar, Adam A. Powell, Diana L. Ordin, Ziad F. Gellad, David Abbott, James M. Schlosser, Janis Hersh, and Dawn Provenzale

patients with stage II–III colon cancer without preoperative obstructing lesions and at least a year of follow-up at the time of data abstraction had a documented colonoscopy within 1 year of surgery. Among patients who had a follow-up colonoscopy, the

Full access

Francis P. Worden and Huan Ha

: 1944 – 1956 . 10. Sanchez MJ Martinez C Nieto A . Oral and oropharyngeal cancer in Spain: influence of dietary patterns . Eur J Cancer Prev 2003 ; 12 : 49 – 56 . 11. Hicks WL Jr Kuriakose MA Loree TR . Surgery versus radiation

Full access

Estanislao Arana, Francisco M. Kovacs, Ana Royuela, Beatriz Asenjo, Úrsula Pérez-Ramírez, Javier Zamora, and the Spanish Back Pain Research Network Task Force for the Improvement of Inter-Disciplinary Management of Spinal Metastasis

. Sample size calculations were performed using κ size package of the R library. 11 The 61 hospital departments specializing in radiology, medical oncology, radiation oncology, neurosurgery, and orthopedic surgery, which had previously participated in

Full access

Stefanie L. Thorsness, Azael Freites-Martinez, Michael A. Marchetti, Cristian Navarrete-Dechent, Mario E. Lacouture, and Emily S. Tonorezos

size or aggressive histologic subtype. Surgery is recommended for primary BCCs and SCCs, but the recommended surgical approaches differ according to risk category. 20 , 21 We aimed to characterize the clinical features, histology, management, and

Full access

Heidi Ko, Yaser Baghdadi, Charito Love, and Joseph A. Sparano

advanced disease; it results in the downstaging of breast and regional nodal disease burden and facilitates breast conservation and/or less extensive axillary surgery. 2 Upstaging to a higher regional stage or detection of metastatic disease may impact

Full access

Richard L. Theriault, J. Sybil Biermann, Elizabeth Brown, Adam Brufsky, Laurence Demers, Ravinder K. Grewal, Theresa Guise, Rebecca Jackson, Kevin McEnery, Donald Podoloff, Peter Ravdin, Charles L. Shapiro, Matthew Smith, and Catherine H. Van Poznak

, therapeutic strategies to maintain bone health, and treatment of bone metastases, including surgery for pathologic fractures. Multiple members of the health care team may be needed for effective patient care and education. This report summarizes presentations

Full access

Robert W. Carlson, Elizabeth Brown, Harold J. Burstein, William J. Gradishar, Clifford A. Hudis, Charles Loprinzi, Eleftherios Paul Mamounas, Edith A. Perez, Kathleen Pritchard, Peter Ravdin, Abram Recht, George Somlo, Richard L. Theriault, Eric P. Winer, Antonio C. Wolff, and for the NCCN Adjuvant Therapy for Breast Cancer Task Force

persists despite adjuvant therapy in many patients with breast cancer for up to 4 years after surgery. 14 Reports on the prognostic value of minimal residual disease detection show conflicting results. In a systematic review of published studies, minimal